title: Polymorphisms of TGFB1 and VEGF genes and survival of patients with gastric cancer.
abstract: BACKGROUND
  Some TGFB1 and VEGF polymorphisms are believed to be functional. Given that these genes are involved in tumor growth and progression including angiogenesis, dissemination, and invasiveness, we hypothesized that these polymorphisms would be associated with survival in patients with gastric cancer.
  
  
  METHODS
  We genotyped TGFB1 -509 C>T, +1869 T>C, and +915 G>C and VEGF -1498T>C, -634G>C, and +936C>T in 167 patients with gastric cancer. Using the Kaplan and Meier method, log-rank tests, and Cox proportional hazard models, we evaluated associations among TGFB1 and VEGF variants with overall, 1-year, and 2-year survival rates.
  
  
  RESULTS
  Although there were no significant differences in overall survival rates among all polymorphisms tested, patients with TGFB1+915CG and CC genotypes had a poorer 2-year survival (adjusted hazard ratio (HR), 3.06; 95% confidence interval (CI), 1.09-8.62; P = 0.034) than patients with the GG genotype had. In addition, patients heterozygous for VEGF -634CG also had a poorer 1-year survival (adjusted HR, 2.08; 95% CI, 1.03-4.22; P = 0.042) than patients with the -634GG genotype.
  
  
  CONCLUSIONS
  Our study suggested that TGFB1+915CG/CC and VEGF -634CG genotypes may be associated with short-term survival in gastric cancer patients. However, larger studies are needed to verify these findings.
authors: Department of Epidemiology, The University of Texas M, D, Anderson Cancer Center, Houston, Texas 77030, USA. Xguan@mdanderson.org
authors: Xiaoxiang
authors: X
authors: Guan
authors: Hui
authors: H
authors: Zhao
authors: Jiangong
authors: J
authors: Niu
authors: Dongfeng
authors: D
authors: Tan
authors: Jaffer A
authors: JA
authors: Ajani
authors: Qingyi
authors: Q
authors: Wei
mesh_terms: D000368:Aged; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D015810:Linkage Disequilibrium; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D016016:Proportional Hazards Models; D011446:Prospective Studies; D013274:Stomach Neoplasms / Q000235:genetics* / Q000378:metabolism; D015996:Survival Rate; D053773:Transforming Growth Factor beta1 / Q000235:genetics* / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics* / Q000378:metabolism
chemical_list: D053773:Transforming Growth Factor beta1; D042461:Vascular Endothelial Growth Factor A